Cello Health PLC Director/PDMR Shareholding (5462B)
21 September 2018 - 7:15PM
UK Regulatory
TIDMCLL
RNS Number : 5462B
Cello Health PLC
21 September 2018
21 September 2018
Cello Health plc
("Cello" or the "Group")
Director/PDMR Shareholding
The Group provides the following notification in accordance with
Article 19(3) of the Market Abuse Regulation:
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Alasdair Combe
-------------------------------------- ----------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------
a) Position/status Person closely associated with Jane
Shirley, Joint CEO of Cello Health
Insight and CEO of Cello Health Europe
-------------------------------------- ----------------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------
a) Name Cello Health plc
-------------------------------------- ----------------------------------------------
b) LEI 2138004TZYGZLWQP7N64
-------------------------------------- ----------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------------
a) Description of the Ordinary shares of 10 pence each
financial instrument,
type of instrument
Identification code ISIN: GB00B0310763
-------------------------------------- ----------------------------------------------
b) Nature of the transaction Purchase of ordinary shares
-------------------------------------- ----------------------------------------------
c) Price(s) and volume(s)
--------------------- --------------------
Price(s) Volume(s)
--------------------- --------------------
GBP1.3487 10,000
----------------------------------------------------------------- --------------------
d) Aggregated information
- Aggregated volume 10,000
- Price GBP13,487.00
-------------------------------------- ---------------------------------------------------
e) Date of the transaction 20 September 2018
-------------------------------------- ----------------------------------------------
f) Place of the transaction AIMX
-------------------------------------- ----------------------------------------------
Enquiries:
Cello Health plc 020 7812 8460
Mark Scott, Chief Executive
Mark Bentley, Finance Director
Cenkos Securities plc 0207 397 8900
Mark Connelly
Harry Hargreaves
Notes to Editors
Cello Health plc is a global healthcare-focused advisory Group
comprised of a set of leading clinical, commercial advisory and
digital delivery capabilities. Cello Health plc currently services
24 of the top 25 pharmaceutical clients globally, as well as a wide
range of biotech, diagnostics, devices and other key non-healthcare
clients.
Cello Health plc enables clients to commercialise, differentiate
their assets, and drive brand success in ever more complex global
markets. The business delivers its services through nearly 1,000
highly skilled professionals, utilising latest thinking, technology
and digital solutions.
Cello Health plc delivers its services from an office network in
the UK, USA, and Asia, with hub offices in New York City,
Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.
For further information, please visit:
https://cellohealthplc.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFKDDKCBKKFCB
(END) Dow Jones Newswires
September 21, 2018 05:15 ET (09:15 GMT)
Cello Health (LSE:CLL)
Historical Stock Chart
From Apr 2024 to May 2024
Cello Health (LSE:CLL)
Historical Stock Chart
From May 2023 to May 2024